Strive Financial Group’s Roivant Sciences ROIV Stock Holding History

Strive Financial Group’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.32K	Hold	235	–	–	﹤0.01%	477
2026 Q1	$7K	Buy	+235	New	+$6.04K	﹤0.01%	468

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Strive Financial Group's ROIV Position: Q2 2026 in Review

Strive Financial Group held its Roivant Sciences (ROIV) position steady in Q2 2026 at 235 shares worth $8.32K. The position accounts for ﹤0.01% of the portfolio, ranked #477.

Strive Financial Group first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 496 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Strive Financial Group held 235 shares of Roivant Sciences worth $8.32K as of Q2 2026.
Strive Financial Group left its Roivant Sciences share count unchanged in Q2 2026.
Roivant Sciences made up ﹤0.01% of Strive Financial Group's portfolio in Q2 2026, its #477 holding.
Strive Financial Group first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
496 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Strive Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.